How should a transwoman with penile pain occurring only during erections be evaluated and managed?

Penile Pain During Erection in Transgender Women

A transgender woman experiencing penile pain only during erections requires urgent evaluation to distinguish between priapism (if erections are prolonged >4 hours) versus pain during normal erectile function, as the former is a medical emergency requiring immediate intervention while the latter warrants investigation for underlying causes related to hormone therapy, anatomical changes, or other pathology.

Initial Assessment

Critical First Step: Duration of Erection

• If erection duration >4 hours with pain: This represents acute ischemic priapism requiring emergency management 1
• If pain occurs during normal-duration erections (<4 hours): Proceed with comprehensive evaluation for other etiologies 1

Key History Elements to Obtain

• Baseline erectile function prior to gender-affirming hormone therapy (GAHT) 1
• Duration and rigidity of painful erections 1
• Degree and character of pain (sharp, aching, burning) 1
• Timing of GAHT initiation and current regimen (estrogen, anti-androgens, progesterone) 2
• Previous episodes of similar pain or priapism 1
• Use of erectogenic medications (PDE5 inhibitors, intracavernosal injections) 3
• History of perineal or genital trauma 1
• Presence of penile curvature or plaques suggesting Peyronie's disease 4

Physical Examination Specifics

• Examine corpora cavernosa for rigidity and tenderness during episode if possible 1
• Assess for penile plaques or fibrosis 4
• Evaluate perineum and genitalia for trauma, masses, or anatomical abnormalities 1
• Note if glans penis and corpus spongiosum are affected (typically spared in priapism) 1

Diagnostic Workup

If Presenting During Painful Erection

• Obtain corporal blood gas immediately to differentiate ischemic from non-ischemic priapism 1
  • Ischemic: hypoxic, hypercarbic, acidotic 1, 5
  • Non-ischemic: normal oxygenation 5
• Consider penile duplex Doppler ultrasound if diagnosis remains indeterminate 1

Additional Testing

• Screen for sexually transmitted infections as these can cause penile pain 3
• Assess testosterone and estrogen levels to evaluate GAHT effects 2
• Consider imaging if structural abnormality suspected 1

Management Algorithm

For Acute Ischemic Priapism (>4 hours, rigid, painful)

This is a medical emergency requiring immediate treatment to prevent permanent erectile dysfunction 1, 5

Step 1: Initial Conservative Measures (if <4 hours)

• Apply ice to penis 6
• Encourage ejaculation or exercise 6
• Consider oral adrenergic agents: pseudoephedrine, ephedrine, or terbutaline 7

Step 2: Intracavernosal Phenylephrine (Primary Treatment)

• Administer intracavernosal phenylephrine as first-line intervention 1, 6
• This is highly effective and should be used promptly 6
• Monitor blood pressure and heart rate during administration 6

Step 3: Escalation if Phenylephrine Fails

• Corporal aspiration with or without irrigation 1
• Distal shunting procedures if aspiration unsuccessful 1
• Early penile prosthesis placement may be considered in refractory cases 1

Critical timing: Permanent damage to corpora cavernosa occurs if priapism persists >6 hours untreated 7

For Pain During Normal-Duration Erections

Hormone Therapy-Related Considerations

• Estrogen and anti-androgen therapy can alter penile tissue and erectile physiology 2, 8
• Sexual dysfunction is common in transgender women on GAHT, with up to 29% experiencing orgasm difficulties 9
• Pain may represent tissue changes from hormonal effects on penile vasculature and smooth muscle 2

Specific Etiologies to Address

Peyronie's Disease:

• NSAIDs for active-phase penile pain 4
• Daily tadalafil 5 mg may reduce progression and improve symptoms 4
• Avoid ineffective oral treatments (vitamin E, pentoxifylline, tamoxifen) that delay effective intervention 4

Erectile Dysfunction with Pain:

• Assess if patient desires preserved erectile function as many transgender women do 10
• Consider PDE5 inhibitors if erectile dysfunction coexists 4
• Avoid intracavernosal injections unless specifically indicated, as these carry priapism risk 7

Scar Tissue or Anatomical Changes:

• Penile pain and scar tissue have been reported in transgender women 3
• Surgical evaluation may be needed if structural abnormality identified 3

Common Pitfalls to Avoid

• Do not dismiss pain as "expected" from GAHT without proper evaluation 8, 3
• Do not delay treatment if priapism suspected—permanent erectile dysfunction risk increases significantly after 6 hours 7
• Do not assume patient does not desire erectile function because of transgender identity—many transgender women wish to preserve sexual function 10
• Avoid misgendering or dysphoria-inducing interactions during evaluation, as this creates barriers to care 2
• Do not prescribe ineffective treatments for Peyronie's disease that delay appropriate intervention 4

Follow-Up Considerations

• Sexual counseling should be offered as sexual dysfunction is common in transgender populations regardless of treatment stage 9
• Monitor for recurrence if stuttering priapism pattern develops 5
• Reassess GAHT regimen with endocrinology if hormonal effects suspected 2
• Document outcomes and maintain open communication about sexual health throughout gender-affirming care 2, 8